Citation | Barlind, JG; Bauer, UA; Birch, AM; Birtles, S; Buckett, LK; Butlin, RJ; Davies, RD; Eriksson, JW; Hammond, CD; Hovland, R; Johannesson, P; Johansson, MJ; Kemmitt, PD; Lindmark, BT; Morentin Gutierrez, P; Noeske, TA; Nordin, A; O'Donnell, CJ; Petersson, AU; Redzic, A; Turnbull, AV; Vinblad, J Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem55:10610-29 (2012) [PubMed] Article |
---|
SMILES | Cc1nc(C)c(nc1C(N)=O)-c1ccc2c(CC[C@]22CC[C@@H](CC2)C(O)=O)c1 |r,wU:21.26,wD:18.18,(32.89,-23.7,;34.23,-22.93,;35.57,-23.7,;36.9,-22.92,;38.23,-23.69,;36.9,-21.39,;35.56,-20.62,;34.23,-21.38,;32.9,-20.61,;31.56,-21.38,;32.9,-19.07,;38.23,-20.62,;38.23,-19.08,;39.56,-18.31,;40.89,-19.07,;40.9,-20.61,;42.37,-21.08,;43.27,-19.83,;42.35,-18.58,;43.84,-18.17,;44.23,-16.69,;43.14,-15.61,;41.65,-16.01,;41.26,-17.5,;43.53,-14.12,;45.02,-13.71,;42.44,-13.03,;39.56,-21.39,)| |